ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-1Y3173
Home | Market Reports | Health| Pharmacy
Global Phosphodiesterase Type 5 PDE5 Inhibitor Market Insights Forecast to 2028
BUY CHAPTERS

Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Research Report 2025

Code: QYRE-Auto-1Y3173
Report
March 2025
Pages:89
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Eli Lilly
Pfizer Inc
Bayer
BaiYunShan General Factory
SK Chemicals
Teva Pharma
Seoul Pharma
Jiangsu Yabang
VIVUS
Fujian Cosunter
Youcare Pharmaceutical

Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size

The global market for Phosphodiesterase Type 5 (PDE5) Inhibitor was valued at US$ 2370 million in the year 2024 and is projected to reach a revised size of US$ 2806 million by 2031, growing at a CAGR of 2.5% during the forecast period.

Phosphodiesterase Type 5 (PDE5) Inhibitor Market

Phosphodiesterase Type 5 (PDE5) Inhibitor Market

Phosphodiesterase type 5 (PDE5) inhibitor is a class of medication that specifically targets and blocks the enzyme phosphodiesterase type 5. This enzyme is primarily found in the smooth muscle cells of the blood vessels, including those in the penis and lungs. By inhibiting PDE5, these medications promote the accumulation of cyclic guanosine monophosphate (cGMP), a chemical responsible for relaxing the smooth muscles and increasing blood flow in these areas. In the context of erectile dysfunction (ED), PDE5 inhibitors help improve blood flow to the penis, facilitating and maintaining erections. They are also used in the treatment of pulmonary arterial hypertension (PAH) to reduce blood vessel constriction and lower blood pressure in the lungs.
The key players of Phosphodiesterase Type 5 (PDE5) Inhibitor include Eli Lilly, Pfizer and Bayer, etc. The top three players hold a share over 65%. Asia-Pacific is the largest market, has a share about 34%. In terms of product type, Sildenafil is the largest segment, occupied for a share of about 72%, and for application ,and in terms of application, Retail Pharmacy has a share about 49%.
This report aims to provide a comprehensive presentation of the global market for Phosphodiesterase Type 5 (PDE5) Inhibitor, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Phosphodiesterase Type 5 (PDE5) Inhibitor.
The Phosphodiesterase Type 5 (PDE5) Inhibitor market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Phosphodiesterase Type 5 (PDE5) Inhibitor market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Phosphodiesterase Type 5 (PDE5) Inhibitor companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Phosphodiesterase Type 5 (PDE5) Inhibitor Market Report

Report Metric Details
Report Name Phosphodiesterase Type 5 (PDE5) Inhibitor Market
Accounted market size in year US$ 2370 million
Forecasted market size in 2031 US$ 2806 million
CAGR 2.5%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Eli Lilly, Pfizer, Bayer, BaiYunShan General Factory, Teva Pharma, SK Chemicals, Seoul Pharma, Jiangsu Yabang, VIVUS, Fujian Cosunter, Youcare Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Phosphodiesterase Type 5 (PDE5) Inhibitor company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Phosphodiesterase Type 5 (PDE5) Inhibitor Market growing?

Ans: The Phosphodiesterase Type 5 (PDE5) Inhibitor Market witnessing a CAGR of 2.5% during the forecast period 2025-2031.

What is the Phosphodiesterase Type 5 (PDE5) Inhibitor Market size in 2031?

Ans: The Phosphodiesterase Type 5 (PDE5) Inhibitor Market size in 2031 will be US$ 2806 million.

What is the market share of major companies in Phosphodiesterase Type 5 (PDE5) Inhibitor Market?

Ans: The top three players hold a share over 65%.

What is the Phosphodiesterase Type 5 (PDE5) Inhibitor Market share by region?

Ans: Asia-Pacific is the largest market, has a share about 34%.

What is the Phosphodiesterase Type 5 (PDE5) Inhibitor Market share by type?

Ans: In terms of product type, Sildenafil is the largest segment, occupied for a share of about 72%, and for application ,and in terms of application, Retail Pharmacy has a share about 49%.

Who are the main players in the Phosphodiesterase Type 5 (PDE5) Inhibitor Market report?

Ans: The main players in the Phosphodiesterase Type 5 (PDE5) Inhibitor Market are Eli Lilly, Pfizer, Bayer, BaiYunShan General Factory, Teva Pharma, SK Chemicals, Seoul Pharma, Jiangsu Yabang, VIVUS, Fujian Cosunter, Youcare Pharmaceutical

What are the Application segmentation covered in the Phosphodiesterase Type 5 (PDE5) Inhibitor Market report?

Ans: The Applications covered in the Phosphodiesterase Type 5 (PDE5) Inhibitor Market report are Hospital, Retail Pharmacy, Online Pharmacies, Other

What are the Type segmentation covered in the Phosphodiesterase Type 5 (PDE5) Inhibitor Market report?

Ans: The Types covered in the Phosphodiesterase Type 5 (PDE5) Inhibitor Market report are Sildenafil, Tadalafil, Avanafil, Vardenafil, Others

Recommended Reports

Erectile Dysfunction Markets

Pulmonary & Cardiovascular Drugs

Inhibitors & Related Drugs

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Sildenafil
1.2.3 Tadalafil
1.2.4 Avanafil
1.2.5 Vardenafil
1.2.6 Others
1.3 Market by Application
1.3.1 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacies
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Perspective (2020-2031)
2.2 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Growth Trends by Region
2.2.1 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Phosphodiesterase Type 5 (PDE5) Inhibitor Historic Market Size by Region (2020-2025)
2.2.3 Phosphodiesterase Type 5 (PDE5) Inhibitor Forecasted Market Size by Region (2026-2031)
2.3 Phosphodiesterase Type 5 (PDE5) Inhibitor Market Dynamics
2.3.1 Phosphodiesterase Type 5 (PDE5) Inhibitor Industry Trends
2.3.2 Phosphodiesterase Type 5 (PDE5) Inhibitor Market Drivers
2.3.3 Phosphodiesterase Type 5 (PDE5) Inhibitor Market Challenges
2.3.4 Phosphodiesterase Type 5 (PDE5) Inhibitor Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Phosphodiesterase Type 5 (PDE5) Inhibitor Players by Revenue
3.1.1 Global Top Phosphodiesterase Type 5 (PDE5) Inhibitor Players by Revenue (2020-2025)
3.1.2 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Share by Players (2020-2025)
3.2 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue
3.4 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Concentration Ratio
3.4.1 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue in 2024
3.5 Global Key Players of Phosphodiesterase Type 5 (PDE5) Inhibitor Head office and Area Served
3.6 Global Key Players of Phosphodiesterase Type 5 (PDE5) Inhibitor, Product and Application
3.7 Global Key Players of Phosphodiesterase Type 5 (PDE5) Inhibitor, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Phosphodiesterase Type 5 (PDE5) Inhibitor Breakdown Data by Type
4.1 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Historic Market Size by Type (2020-2025)
4.2 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Forecasted Market Size by Type (2026-2031)
5 Phosphodiesterase Type 5 (PDE5) Inhibitor Breakdown Data by Application
5.1 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Historic Market Size by Application (2020-2025)
5.2 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size (2020-2031)
6.2 North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2020-2025)
6.4 North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size (2020-2031)
7.2 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2020-2025)
7.4 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size (2020-2031)
8.2 Asia-Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Region (2020-2025)
8.4 Asia-Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size (2020-2031)
9.2 Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2020-2025)
9.4 Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size (2020-2031)
10.2 Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2020-2025)
10.4 Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Details
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.1.4 Eli Lilly Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2020-2025)
11.1.5 Eli Lilly Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.2.4 Pfizer Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2020-2025)
11.2.5 Pfizer Recent Development
11.3 Bayer
11.3.1 Bayer Company Details
11.3.2 Bayer Business Overview
11.3.3 Bayer Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.3.4 Bayer Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2020-2025)
11.3.5 Bayer Recent Development
11.4 BaiYunShan General Factory
11.4.1 BaiYunShan General Factory Company Details
11.4.2 BaiYunShan General Factory Business Overview
11.4.3 BaiYunShan General Factory Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.4.4 BaiYunShan General Factory Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2020-2025)
11.4.5 BaiYunShan General Factory Recent Development
11.5 Teva Pharma
11.5.1 Teva Pharma Company Details
11.5.2 Teva Pharma Business Overview
11.5.3 Teva Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.5.4 Teva Pharma Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2020-2025)
11.5.5 Teva Pharma Recent Development
11.6 SK Chemicals
11.6.1 SK Chemicals Company Details
11.6.2 SK Chemicals Business Overview
11.6.3 SK Chemicals Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.6.4 SK Chemicals Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2020-2025)
11.6.5 SK Chemicals Recent Development
11.7 Seoul Pharma
11.7.1 Seoul Pharma Company Details
11.7.2 Seoul Pharma Business Overview
11.7.3 Seoul Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.7.4 Seoul Pharma Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2020-2025)
11.7.5 Seoul Pharma Recent Development
11.8 Jiangsu Yabang
11.8.1 Jiangsu Yabang Company Details
11.8.2 Jiangsu Yabang Business Overview
11.8.3 Jiangsu Yabang Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.8.4 Jiangsu Yabang Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2020-2025)
11.8.5 Jiangsu Yabang Recent Development
11.9 VIVUS
11.9.1 VIVUS Company Details
11.9.2 VIVUS Business Overview
11.9.3 VIVUS Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.9.4 VIVUS Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2020-2025)
11.9.5 VIVUS Recent Development
11.10 Fujian Cosunter
11.10.1 Fujian Cosunter Company Details
11.10.2 Fujian Cosunter Business Overview
11.10.3 Fujian Cosunter Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.10.4 Fujian Cosunter Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2020-2025)
11.10.5 Fujian Cosunter Recent Development
11.11 Youcare Pharmaceutical
11.11.1 Youcare Pharmaceutical Company Details
11.11.2 Youcare Pharmaceutical Business Overview
11.11.3 Youcare Pharmaceutical Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.11.4 Youcare Pharmaceutical Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2020-2025)
11.11.5 Youcare Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Eli Lilly
Pfizer Inc
Bayer
BaiYunShan General Factory
SK Chemicals
Teva Pharma
Seoul Pharma
Jiangsu Yabang
VIVUS
Fujian Cosunter
Youcare Pharmaceutical
List of Tables
 Table 1. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Sildenafil
 Table 3. Key Players of Tadalafil
 Table 4. Key Players of Avanafil
 Table 5. Key Players of Vardenafil
 Table 6. Key Players of Others
 Table 7. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Region (2020-2025) & (US$ Million)
 Table 10. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Region (2020-2025)
 Table 11. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 12. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Region (2026-2031)
 Table 13. Phosphodiesterase Type 5 (PDE5) Inhibitor Market Trends
 Table 14. Phosphodiesterase Type 5 (PDE5) Inhibitor Market Drivers
 Table 15. Phosphodiesterase Type 5 (PDE5) Inhibitor Market Challenges
 Table 16. Phosphodiesterase Type 5 (PDE5) Inhibitor Market Restraints
 Table 17. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue by Players (2020-2025) & (US$ Million)
 Table 18. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Players (2020-2025)
 Table 19. Global Top Phosphodiesterase Type 5 (PDE5) Inhibitor Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor as of 2024)
 Table 20. Ranking of Global Top Phosphodiesterase Type 5 (PDE5) Inhibitor Companies by Revenue (US$ Million) in 2024
 Table 21. Global 5 Largest Players Market Share by Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue (CR5 and HHI) & (2020-2025)
 Table 22. Global Key Players of Phosphodiesterase Type 5 (PDE5) Inhibitor, Headquarters and Area Served
 Table 23. Global Key Players of Phosphodiesterase Type 5 (PDE5) Inhibitor, Product and Application
 Table 24. Global Key Players of Phosphodiesterase Type 5 (PDE5) Inhibitor, Date of Enter into This Industry
 Table 25. Mergers & Acquisitions, Expansion Plans
 Table 26. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2020-2025) & (US$ Million)
 Table 27. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Share by Type (2020-2025)
 Table 28. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 29. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Share by Type (2026-2031)
 Table 30. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2020-2025) & (US$ Million)
 Table 31. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Share by Application (2020-2025)
 Table 32. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 33. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Share by Application (2026-2031)
 Table 34. North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2020-2025) & (US$ Million)
 Table 36. North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2020-2025) & (US$ Million)
 Table 39. Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2026-2031) & (US$ Million)
 Table 40. Asia-Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Asia-Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Region (2020-2025) & (US$ Million)
 Table 42. Asia-Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Region (2026-2031) & (US$ Million)
 Table 43. Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 47. Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2020-2025) & (US$ Million)
 Table 48. Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2026-2031) & (US$ Million)
 Table 49. Eli Lilly Company Details
 Table 50. Eli Lilly Business Overview
 Table 51. Eli Lilly Phosphodiesterase Type 5 (PDE5) Inhibitor Product
 Table 52. Eli Lilly Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2020-2025) & (US$ Million)
 Table 53. Eli Lilly Recent Development
 Table 54. Pfizer Company Details
 Table 55. Pfizer Business Overview
 Table 56. Pfizer Phosphodiesterase Type 5 (PDE5) Inhibitor Product
 Table 57. Pfizer Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2020-2025) & (US$ Million)
 Table 58. Pfizer Recent Development
 Table 59. Bayer Company Details
 Table 60. Bayer Business Overview
 Table 61. Bayer Phosphodiesterase Type 5 (PDE5) Inhibitor Product
 Table 62. Bayer Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2020-2025) & (US$ Million)
 Table 63. Bayer Recent Development
 Table 64. BaiYunShan General Factory Company Details
 Table 65. BaiYunShan General Factory Business Overview
 Table 66. BaiYunShan General Factory Phosphodiesterase Type 5 (PDE5) Inhibitor Product
 Table 67. BaiYunShan General Factory Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2020-2025) & (US$ Million)
 Table 68. BaiYunShan General Factory Recent Development
 Table 69. Teva Pharma Company Details
 Table 70. Teva Pharma Business Overview
 Table 71. Teva Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Product
 Table 72. Teva Pharma Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2020-2025) & (US$ Million)
 Table 73. Teva Pharma Recent Development
 Table 74. SK Chemicals Company Details
 Table 75. SK Chemicals Business Overview
 Table 76. SK Chemicals Phosphodiesterase Type 5 (PDE5) Inhibitor Product
 Table 77. SK Chemicals Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2020-2025) & (US$ Million)
 Table 78. SK Chemicals Recent Development
 Table 79. Seoul Pharma Company Details
 Table 80. Seoul Pharma Business Overview
 Table 81. Seoul Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Product
 Table 82. Seoul Pharma Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2020-2025) & (US$ Million)
 Table 83. Seoul Pharma Recent Development
 Table 84. Jiangsu Yabang Company Details
 Table 85. Jiangsu Yabang Business Overview
 Table 86. Jiangsu Yabang Phosphodiesterase Type 5 (PDE5) Inhibitor Product
 Table 87. Jiangsu Yabang Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2020-2025) & (US$ Million)
 Table 88. Jiangsu Yabang Recent Development
 Table 89. VIVUS Company Details
 Table 90. VIVUS Business Overview
 Table 91. VIVUS Phosphodiesterase Type 5 (PDE5) Inhibitor Product
 Table 92. VIVUS Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2020-2025) & (US$ Million)
 Table 93. VIVUS Recent Development
 Table 94. Fujian Cosunter Company Details
 Table 95. Fujian Cosunter Business Overview
 Table 96. Fujian Cosunter Phosphodiesterase Type 5 (PDE5) Inhibitor Product
 Table 97. Fujian Cosunter Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2020-2025) & (US$ Million)
 Table 98. Fujian Cosunter Recent Development
 Table 99. Youcare Pharmaceutical Company Details
 Table 100. Youcare Pharmaceutical Business Overview
 Table 101. Youcare Pharmaceutical Phosphodiesterase Type 5 (PDE5) Inhibitor Product
 Table 102. Youcare Pharmaceutical Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2020-2025) & (US$ Million)
 Table 103. Youcare Pharmaceutical Recent Development
 Table 104. Research Programs/Design for This Report
 Table 105. Key Data Information from Secondary Sources
 Table 106. Key Data Information from Primary Sources
 Table 107. Authors List of This Report


List of Figures
 Figure 1. Phosphodiesterase Type 5 (PDE5) Inhibitor Picture
 Figure 2. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Type: 2024 VS 2031
 Figure 4. Sildenafil Features
 Figure 5. Tadalafil Features
 Figure 6. Avanafil Features
 Figure 7. Vardenafil Features
 Figure 8. Others Features
 Figure 9. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2020-2031) & (US$ Million)
 Figure 10. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Application: 2024 VS 2031
 Figure 11. Hospital Case Studies
 Figure 12. Retail Pharmacy Case Studies
 Figure 13. Online Pharmacies Case Studies
 Figure 14. Other Case Studies
 Figure 15. Phosphodiesterase Type 5 (PDE5) Inhibitor Report Years Considered
 Figure 16. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 17. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 18. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Region: 2024 VS 2031
 Figure 19. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Players in 2024
 Figure 20. Global Top Phosphodiesterase Type 5 (PDE5) Inhibitor Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor as of 2024)
 Figure 21. The Top 10 and 5 Players Market Share by Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue in 2024
 Figure 22. North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Country (2020-2031)
 Figure 24. United States Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Canada Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Country (2020-2031)
 Figure 28. Germany Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. France Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. U.K. Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Italy Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Russia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Nordic Countries Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Asia-Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Region (2020-2031)
 Figure 36. China Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Japan Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. South Korea Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. India Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Australia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Country (2020-2031)
 Figure 44. Mexico Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Brazil Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Country (2020-2031)
 Figure 48. Turkey Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. UAE Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. Eli Lilly Revenue Growth Rate in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2020-2025)
 Figure 52. Pfizer Revenue Growth Rate in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2020-2025)
 Figure 53. Bayer Revenue Growth Rate in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2020-2025)
 Figure 54. BaiYunShan General Factory Revenue Growth Rate in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2020-2025)
 Figure 55. Teva Pharma Revenue Growth Rate in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2020-2025)
 Figure 56. SK Chemicals Revenue Growth Rate in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2020-2025)
 Figure 57. Seoul Pharma Revenue Growth Rate in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2020-2025)
 Figure 58. Jiangsu Yabang Revenue Growth Rate in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2020-2025)
 Figure 59. VIVUS Revenue Growth Rate in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2020-2025)
 Figure 60. Fujian Cosunter Revenue Growth Rate in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2020-2025)
 Figure 61. Youcare Pharmaceutical Revenue Growth Rate in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2020-2025)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global Apremilast API Market Research Report 2024
Global Phosphodiesterase PDE inhibitors Market Insights Forecast to 2030
Global PDE3 PDE4 Inhibitors Market Research Report 2024
Global Avanafil API Market Research Report 2025
Global Vardenafil Market Insights Forecast to 2030
Global Tadalafil Oral Market Insights Forecast to 2030
Global Tadalafil API Market Research Report 2025
Global 5α Reductase Inhibitors Market Research Report 2025
Global Udenafil Market Research Report 2025
Global PDE Inhibitors Market Research Report 2024
Global Milrinone Reagent Market Research Report 2024
Global Papaverine Hydrochloride Injection Market Insights Forecast to 2030
Global Milrinone API Market Research Report 2024
Amrinone Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Erectile Dysfunction Treatment Market Insights Forecast to 2030
Global Phosphodiesterase Inhibitor Market Research Report 2025
Protoporphyrinogen Oxidase Inhibitor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Endothelin Antagonists Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Erectile Dysfunction Oral Medications Market Research Report 2025
Global VEGF Inhibitors Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions